Related Experiment Video
Updated: Dec 12, 2025

06:52
CRISPR-Cas9-Mediated Precise Knock-In Edits in Zebrafish Hearts
Published on: September 13, 2022
3.8K
Thyroid Hormone Receptor α Mutations Cause Heart Defects in Zebrafish
Cho Rong Han1, Hui Wang1, Victoria Hoffmann2
1Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Summary
Thyroid hormone receptor alpha 1 (TRα1) mutations cause resistance to thyroid hormone (RTHα), leading to heart abnormalities. Zebrafish models reveal TRα1 mutants disrupt heart structure, contractility, and sarcomere organization, offering insights into RTHα-related bradycardia.
Area of Science:
- Developmental Biology
- Endocrinology
- Cardiovascular Research
Background:
- Mutations in thyroid hormone receptor alpha 1 (TRα1) cause resistance to thyroid hormone (RTHα), manifesting as growth retardation and bradycardia.
- Previous studies in mouse models elucidated TRα1 mutant actions in adults, but effects during development remained unclear.
Purpose of the Study:
- To investigate the impact of TRα1 mutations on heart development and function in zebrafish.
- To understand the molecular mechanisms underlying cardiac abnormalities in RTHα.
Main Methods:
- CRISPR/Cas9-mediated mutagenesis to create TRα1 C-terminal mutations in zebrafish (thraa and thrab genes).
- Histological analysis, gene expression profiling, confocal fluorescence, and transmission electron microscopy (TEM) were employed.
- Phenotypic analysis of mutant fish hearts at various developmental stages.
Main Results:
- Mutant zebrafish exhibited dilated atria and abnormally shaped ventricles.
- Weakened cardiac contractility was indicated by red blood cell retention, reduced blood speed, and suppressed contractile gene expression.
- TEM revealed disrupted sarcomere organization, linked to bradycardia in mutant fish.
Conclusions:
- TRα1 mutants cause abnormal heart structure, impaired contractility, and disrupted sarcomere organization in zebrafish.
- These findings provide novel insights into the cardiac dysfunction, particularly bradycardia, observed in RTHα patients.

